DHL Group News and Resources

DHL Group has announced a strategic investment of €2 billion over the next five years to enhance its logistics operations in the Life Sciences & Healthcare (LSH) sector. The initiative is part of the Group’s “Strategy 2030” and aims to build

DHL Group has expanded its life sciences and healthcare logistics business with the acquisition of CRYOPDP, a specialized courier service provider handling over 600,000 shipments annually across 135 countries. The acquisition aligns with DHL’s Strategy 2030, reinforcing its capabilities in temperature-controlled networks